A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The study will determine the safety, tolerability, and pharmacokinetics of aripiprazole
lauroxil in adults with schizophrenia or schizoaffective disorder.